From a biological perspective, treatments such as chemotherapy and radiotherapy increase TIL proportions, providing a rationale for combining them with ICIs,24 with anti-PD-1 and anti-PD-L1 antibodies which enhance the ability of the immune system to effectively attack cancer. Here, PDCD1 is linked to cancer.